Heterogeneity in susceptibility to metronidazole among Helicobacter pylori isolates from patients with gastritis or peptic ulcer disease.

Combination therapies that include metronidazole (MTZ) are the most successful therapies used in eradicating Helicobacter pylori. In this study, the prevalence and the relevance of heterogeneity in susceptibility to MTZ among H. pylori populations of 156 patients were evaluated. The results of this...

Descripció completa

Guardat en:

Dades bibliogràfiques
Publicat a:	J Clin Microbiol
Autors principals:	Weel, J F, van der Hulst, R W, Gerrits, Y, Tytgat, G N, van der Ende, A, Dankert, J
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1996
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC229209/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8862577/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.34.9.2158-2162.1996
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Heterogeneity in susceptibility to metronidazole among Helicobacter pylori isolates from patients with gastritis or peptic ulcer disease.

Ítems similars